Celecox Capsule (Celecoxib)

Adult dose

The minimum recommended dose of this medicine should be adjusted according to the patient and may be taken with or without food. Osteoarthritis (degenerative arthritis): Take 200 mg of celecoxib once daily, or 100 mg twice daily. Rheumatoid arthritis: Take 100 mg or 200 mg of celecoxib twice daily. Ankylosing spondylitis (AS): Administer 200 mg of celecoxib once daily, or 100 mg twice daily. If no effect is observed after 6 weeks, the dose may be increased to 400 mg daily. If no effect is observed after 6 weeks of treatment with 400 mg daily, another treatment approach should be considered. Acute pain and primary dysmenorrhea: The recommended initial dose is 400 mg of celecoxib; if needed, an additional 200 mg may be given on the first day of treatment. From the second day onward, the recommended dose, if needed, is 200 mg twice daily. Patients with hepatic impairment: In patients with moderate hepatic impairment (Child-Pugh Class II), the dose should be reduced to approximately 50% of the recommended daily dose.

This medication should be consulted with a doctor or pharmacist before use by individuals who consume alcohol daily in large quantities. Otherwise, serious side effects such as gastrointestinal bleeding may occur. This medication carries a risk of causing problems with the heart or blood vessels, and may increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke. Therefore, it is important to take it at the lowest possible dose and for the shortest duration. It can also affect the gastrointestinal tract, which poses risks of ulcers, bleeding, and perforation, so special care should be taken for patients with gastrointestinal diseases or elderly individuals. If symptoms such as epigastric pain, indigestion, black stools, or vomiting occur during medication, contact a healthcare professional immediately. This medication is not to be given to individuals with certain allergies or diseases. For example, those allergic to the ingredients of this medication, or with severe liver or kidney disorders, active gastric ulcers, heart failure, or pregnant women should not take it. Patients with weakened liver or kidney function, asthma, hypertension, or a history of cardiovascular diseases should use this medication with caution and monitor their condition regularly while on it. Dizziness or drowsiness may occur when taking this medication, so it is advisable to avoid driving or operating machinery. This medication can interact with other drugs, so especially when taking it in conjunction with blood pressure medications, anticoagulants, antidepressants, or immunosuppressants, it is essential to inform your doctor or pharmacist and adjust accordingly. It is safer for pregnant or breastfeeding women not to take this medication, and women planning to become pregnant should consult before taking this medication. If taking this medication for a long time, regular blood tests, liver function tests, and kidney function tests should be conducted, and any abnormal symptoms should be reported to healthcare professionals immediately. This medication is not recommended for use in children and adolescents as safety and efficacy have not been established. Finally, this medication should be kept out of reach of children and should not be transferred to another container.

Gastrointestinal bleeding, cardiovascular thromboembolic reactions, myocardial infarction, stroke, perforation of the upper and lower gastrointestinal tract, ulcers, bleeding, bronchitis, sinusitis, upper respiratory tract infections, urinary tract infections, pharyngitis, rhinitis, anemia, thrombocytopenia, hypersensitivity, insomnia, anxiety, confusion, dizziness, muscle hypertonia, drowsiness, blurred vision, tinnitus, palpitations, congestive heart failure, arrhythmia, tachycardia, hypertension, flushing, cough, vomiting, abdominal pain, diarrhea, dyspepsia, bloating, gastric ulcer, dental disease, duodenal ulcer, esophageal ulcer, intestinal perforation, pancreatitis, elevated liver enzymes, itching, rash, urticaria, angioedema, alopecia, blistering dermatitis, peripheral edema, facial edema, influenza-like illness, injury, taste dysfunction, albuminuria, cystitis, hematuria, dysuria, polyuria, nephrolithiasis, incontinence, visual confusion, cataract, conjunctivitis, eye pain, glaucoma, ocular hemorrhage, retinal artery or vein occlusion, increased serum creatinine, increased β2-microglobulin, increased NAG, positive urine hematuria, positive urine protein, renal impairment, acute renal failure, interstitial nephritis, increased serum sodium, increased serum potassium, increased BUN, increased CPK, diabetes mellitus, hypercholesterolemia, hyperglycemia, hypokalemia, hyperkalemia, increased NPN, increased creatinine, increased alkaline phosphatase, weight gain, anorexia, increased LDH, hypoglycemia, hyponatremia, bursitis, arthralgia, arthritis, skeletal abnormalities, myalgia, cervical dystonia, synovitis, tendinitis, myositis, leg cramps, fractures, tendon rupture, pain in various areas, muscle stiffness, decreased hematocrit, increased hemoglobin, petechiae, epistaxis, thrombocytopathy, agranulocytosis, aplastic anemia, pancytopenia, leukopenia, granulomatous inflammation, contact dermatitis, injection site reactions, skin nodules, headache, dizziness, constipation, thirst, ulcerative stomatitis, gastritis, allergies, low back pain, chest pain, hyperlipidemia, weight gain, fractures, arthralgia, positive RA factor, herpes zoster, pneumonia, dyspnea, elevated ALT, hearing loss, anaphylactic reaction, hallucinations, cerebral hemorrhage, aseptic meningitis, loss of taste, loss of smell, pulmonary embolism, interstitial pneumonia, hepatitis, liver failure, fulminant hepatitis, liver necrosis, cholestasis, cholestatic hepatitis, jaundice, photosensitivity reactions, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, drug rash, acute generalized exanthematous pustulosis, exfoliative dermatitis, acute renal failure, hyponatremia, tubulointerstitial nephritis, nephrotic syndrome, microangiopathic glomerulonephritis, menstrual disorders, female infertility, chest pain

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is recommended to store it in a cool place between 15 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for a longer period.

Appearance

A white capsule filled with white to pale yellow powder with yellow stripes on the top and bottom.

Package unit

For domestic use - 30 capsules/bottle, For domestic use - 100 capsules/bottle, For export - 100 capsules/box [10 capsules/PTP*10], For export - 30 capsules/box [10 capsules/PTP*3]